An anti-cancer compound developed at USA Health Mitchell Cancer Institute is showing promise in pre-clinical studies – one involving pancreatic cancer and the other involving breast cancer. The compound, MCI-715, was developed by Gary Piazza, Ph.D., and his lab team at the Drug Discovery Research Center at MCI.
USA Health Heart Center
At USA Health, our team of heart specialists uses a multidisciplinary approach to treat patients with various heart conditions. Cardiologists, interventional cardiologists, electrophysiologists, nurse practitioners, respiratory therapists, physical therapists and even pharmacists may be involved in determining and providing the appropriate care and treatment. We use a variety of diagnostic tools to assess a patient’s health and, using advanced technology and the latest medications, provide treatment based on American College of Cardiology guidelines.